Benzoic acid, 2-[(3,5-dibromo-4-hydroxyphenyl)(3,5-dibromo-4-oxo-2,5-cyclohexadien-1-ylidene)methyl]-, ethyl ester(Bromophthalein Magenta E)

What is it?

  • Benzoic acid, 2-[(3,5-dibromo-4-hydroxyphenyl)(3,5-dibromo-4-oxo-2,5-cyclohexadien-1-ylidene)methyl]-, ethyl ester, also known as Bromophthalein magenta E, is an industrial chemical compound.

Where is it found and how is it used?

  • Bromophthalein magenta E is used as an acid-base indicator in laboratories.
  • Bromophthalein magenta E is not in commerce in Canada.

Why did the Government of Canada assess It?

  • Bromophthalein magenta E was identified as a potential concern to the environment based on available information regarding possible persistence, accumulation and potential to cause harm to the environment.

What is the Government of Canada doing?

  • The evaluation showed that Bromophthalein magenta E can stay in the environment for a long time. It has the potential to build up in the bodies of animals or within the food chain and small amounts of Bromophthalein magenta E could harm animals or plants that live in the water.
  • However, the Government of Canada has reviewed information that indicates that Bromophthalein magenta E is not currently in commerce in Canada in significant quantities.
  • As a result of these low quantities, it is unlikely that Bromophthalein magenta E is entering the environment as a result of commercial manufacture or use in this country.
  • The Government of Canada is proposing that Bromophthalein magenta E is does not cause harm to the environment.
  • If the proposed conclusion is confirmed in the final assessment, the Government is proposing that Bromophthalein magenta E be subject to a Significant New Activity notice or SNAc. This action would require anyone proposing to manufacture or bring Bromophthalein magenta E into the country to provide information to the Government. Further ecological and human health assessment would them be done by the Government before considering whether to allow such activities.
  • The draft screening assessment was published on January 24, 2009 and will be followed by a 60-day public comment period, ending March 25, 2009.

Page details

Date modified: